查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1870665

消化道出血治療器材市場（依產品類型、技術、應用、最終用戶和適應症類型分類）－2025-2032年全球預測

Gastrointestinal Bleeding Treatment Devices Market by Product Type, Technology, Application, End User, Indication Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，治療消化道出血的設備市場規模將成長至 8.5929 億美元，複合年成長率為 5.51%。

關鍵市場統計數據
基準年 2024 5.5943億美元
預計年份：2025年 5.9093億美元
預測年份 2032 8.5929億美元
複合年成長率 (%) 5.51%

簡要概述影響消化道出血治療器材市場的臨床、技術和商業性因素，以支持明智的策略決策。

消化道出血仍然是一項重大的臨床挑戰，對病患預後、醫院工作流程和醫療設備創新都產生了顯著影響。本執行摘要概述了用於診斷、控制和治療上消化道和下消化道出血的醫療設備現狀，重點關注對醫療保健專業人員、醫院採購團隊和醫療技術負責人至關重要的技術進步、臨床實踐的改變以及商業性壓力。

臨床實踐、醫療設備創新和數據驅動的流程改進的融合正在重塑出血治療器材領域的治療路徑和商業模式。

消化道出血治療器械領域正經歷一系列變革，這主要得益於器械設計、手術技術和數據驅動的臨床支援的進步。微創內視鏡治療的臨床應用範圍不斷擴大，這得益於器械人體工學的改進、一次性附件的選擇以及先進止血材料的運用，這些都縮短了手術時間並降低了手術複雜性。同時，對於內視鏡治療難度較大的病例，放射介入和混合治療方式也日益普及，這體現了多學科協作的治療路徑，旨在透過共同決策最佳化患者預後。

評估供應鏈對2025年關稅實施的應對措施，並調整製造商和供應商的採購、庫存和合約策略，以維持臨床服務的連續性。

2025年關稅及貿易政策調整的實施給醫療設備供應鏈帶來了顯著壓力，尤其對用於消化道出血治療的零件和成品造成了嚴重影響。依賴跨境採購聚合物組件、特殊黏合劑和高精度電子子系統的製造商面臨到岸成本上升的困境，促使他們重新評估其地理籌資策略和庫存管理實踐。為此，多家公司加快了近岸外包的步伐，並實現了供應商多元化，以確保供應的連續性並降低受到額外關稅措施的影響。

全面的細分分析揭示了產品類型、技術方法、臨床應用、最終用戶和適應症亞型如何驅動產品採用趨勢。

為了解胃腸道出血治療器械領域的臨床應用模式和產品開發重點，詳細的細分分析至關重要。依產品類型分類，內鏡夾、止血劑、注射療法和熱凝器械各自具有不同的臨床適應症和操作特性。特別是止血劑，根據其粉末、片狀和噴霧劑型的不同，需要進行更詳細的分析，因為它們在釋放速度和表面相容性方面存在差異。注射療法包括酒精硬化劑、腎上腺素和聚多卡醇，每種藥物的選擇都取決於病變特徵和醫生的偏好。同時，氬等離子體凝固、雙極探針和加熱探針等熱凝器械仍是標靶凝血的核心工具。

區域支付方結構、醫療服務提供方能力和人口趨勢如何塑造全球醫療保健市場的差異化需求模式和技術應用

區域趨勢正顯著影響全球消化道出血治療設備的取得模式、報銷途徑和技術應用。在美洲，一體化的醫院系統和高度集中的供應基地使得採購決策需要在資本支出、手術量和報銷獎勵之間取得平衡，而私人支付方往往對設備選擇和價格談判產生影響。一旦臨床和經濟效益得到明確證實，有組織的臨床網路和相對快速的推廣路徑將促進持續的創新循環。

競爭環境強調整合的產品系列、臨床證據計劃以及能夠加速產品推廣並加強與醫療保健提供者長期關係的模式。

製造商之間的競爭地位日益取決於整合的產品組合、實證實踐能力和服務導向經營模式。領先的醫療設備製造商正在投資開發模組化系統，將止血劑與專用輸送裝置結合，並建立培訓和支援體系，以縮短學習曲線並加速醫院的推廣應用。醫療設備創新者與臨床研究網路之間的策略聯盟正在擴大真實世界數據 (RWE) 的生成，從而提高手術效率並獲得更清晰的臨床結果，這些結果能夠引起臨床醫生和支付方的共鳴。

為製造商和供應商提供切實可行的策略行動，將臨床創新轉化為成功的實施，並加強供應鏈和商業性韌性。

產業領導者應優先考慮一系列切實可行的策略，以提升臨床效用、增強營運韌性並實現商業性差異化。首先，應投資以產生臨床證據，將器械使用與可衡量的結果連結起來，例如降低再出血率、縮短手術時間以及降低治療總成本。這些數據將有助於與支付方進行溝通，並增強醫院的採購決策。其次，在設計器械和輔助系統時，應充分考慮供應鏈冗餘，減少對單一來源組件的依賴，並確保在政策或物流中斷時能夠快速找到替代途徑。

採用穩健的多源方法，結合臨床醫生訪談、監管和技術文件審查以及真實世界證據綜合，以檢驗趨勢和見解。

本研究整合了同行評審的臨床文獻、監管申報文件、產品技術規範以及對執業醫師、醫院採購人員和行業高管的訪談，從而全面展現了當前胃腸道出血治療器材的現狀。主要定性資料是透過對經驗豐富的內視鏡、放射和外科出血管理臨床醫生進行結構化訪談收集的，並輔以與供應鏈和採購負責人的匿名討論，以了解採購限制和合約偏好。

綜合分析關鍵見解，探討臨床創新、供應鏈韌性和實證應用與長期商業性和病患影響之間的關聯。

摘要，消化道出血治療器材領域正處於臨床需求與技術機會的交會點。止血劑、精密內視鏡配件以及輔助放射學手段的進步，正在擴大臨床醫師可用的治療工具。同時，供應鏈壓力和支付方期望的轉變正在重塑產品的採購和使用方式。策略差異化將越來越依賴在特定適應症和醫療環境中證明臨床療效的能力、提供穩健的供應和服務模式，以及提供可擴展的培訓，將新技術融入日常實踐中。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 利用人工智慧內視鏡平台進行即時出血檢測與管理
  • 開發一種新型標靶附著止血粉用於控制上消化道出血
  • 將遠端醫療和遠距監測解決方案整合到農村患者內視鏡術後出血的管理中
  • 生物可分解支架技術的出現及其在治療持續性食道靜脈曲張出血的應用
  • 對於難治性消化道出血，可使用內視鏡止血夾合併注射凝膠進行止血。
  • 內視鏡縫合裝置的進步使得在治療急性消化道出血時精確地閉合缺損。
  • 引入數位健康平台，用於即時數據分析，以追蹤消化道出血的預後

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章消化道出血治療器械市場（按產品類型分類）

  • 內視鏡夾
  • 止血劑
    • 粉末
    • 床單
    • 噴
  • 注射療法
    • 酒精硬化劑
    • 腎上腺素
    • 聚多卡醇
  • 熱凝固設備
    • 氬氣等離子凝固
    • 雙極探針
    • 加熱器探頭

第9章 按技術分類的消化道出血治療設備市場

  • 內視鏡
    • 軟式內視鏡
    • 硬式內視鏡
  • 放射學
    • 血管造影術栓塞術
    • 腸繫膜支架置入術
  • 外科
    • 腹腔鏡手術
    • 開放性手術

第10章 按應用分類的消化道出血治療設備市場

  • 血管畸形
  • 迪厄拉福伊氏病變
  • 馬洛里·韋斯撕裂傷
  • 消化性潰瘍
  • 食道靜脈曲張出血

第11章 依最終使用者分類的消化道出血治療設備市場

  • 門診手術中心
  • 胃腸病診所
  • 醫院（住院部）
  • 醫院門診部

第12章消化道出血治療器械市場（依適應症類型分類）

  • 下消化道
    • 結腸出血
    • 直腸出血
  • 上消化道
    • 十二指腸出血
    • 食道出血
    • 胃出血

第13章 各地區消化道出血治療器材市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章消化道出血治療器械市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國消化道出血治療器材市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Boston Scientific Corporation
    • Medtronic plc
    • Olympus Corporation
    • FUJIFILM Holdings Corporation
    • HOYA Corporation
    • Cook Medical LLC
    • Johnson & Johnson
    • B. Braun Melsungen AG
    • Teleflex Incorporated
    • ConMed Corporation
Product Code: MRR-1A1A064C0286

The Gastrointestinal Bleeding Treatment Devices Market is projected to grow by USD 859.29 million at a CAGR of 5.51% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 559.43 million
Estimated Year [2025] USD 590.93 million
Forecast Year [2032] USD 859.29 million
CAGR (%) 5.51%

A concise orienting overview that frames clinical, technological, and commercial drivers shaping the gastrointestinal bleeding device landscape for informed strategic decision making

Gastrointestinal bleeding remains a critical clinical challenge with significant implications for patient outcomes, hospital workflows, and device innovation. This executive summary synthesizes current dynamics shaping the device landscape used to diagnose, control, and manage bleeding across upper and lower gastrointestinal tracts, emphasizing technological evolution, clinical practice shifts, and commercial pressures that matter to clinicians, hospital procurement teams, and medtech strategists.

The narrative that follows contextualizes the device ecosystem-spanning endoscopic clips, hemostatic agents, injection therapies, and thermal modalities-within the broader movement toward minimally invasive interventions and value-based care. It highlights how procedural preferences, regulatory developments, and payer behavior are influencing product adoption. Throughout, the focus remains practical: identify where clinical need intersects with technological capability and where operational constraints create opportunities for differentiated solutions.

By framing these trends against supply chain realities and emerging policy changes, the introduction sets the stage for granular segmentation, regional variances, corporate competitive positioning, and pragmatic recommendations. Readers will find an integrated view that connects clinical practice to commercial implications and provides a foundation for evidence-informed decision-making.

How converging clinical practices, device innovation, and data-driven procedural enhancements are reshaping treatment pathways and commercial models across the bleeding device landscape

The landscape for gastrointestinal bleeding treatment devices is undergoing a series of transformative shifts driven by advances in device design, procedural technique, and data-enabled clinical support. Minimally invasive endoscopic therapies continue to expand their clinical remit, supported by improvements in device ergonomics, single-use accessory options, and refined hemostatic materials that reduce procedural time and complexity. Concurrently, radiologic and hybrid approaches have gained traction for cases refractory to endoscopic care, reflecting multidisciplinary care pathways that optimize patient outcomes through collaborative decision-making.

Technological convergence is another critical vector of change, with imaging enhancements, artificial intelligence-assisted lesion detection, and integrated hemostasis delivery systems improving the precision and predictability of interventions. These developments are altering training paradigms and shifting competency expectations for endoscopists and interventional radiologists alike. At the same time, commercial dynamics-such as vendor consolidation, strategic partnerships between device manufacturers and hospital systems, and an emphasis on lifecycle cost reduction-are reshaping procurement models, encouraging bundled offerings and service-oriented contracts.

Ultimately, these transformative shifts are accelerating adoption of novel hemostatic agents and procedural adjuncts while tightening the requirements for clinical evidence and real-world outcome data that demonstrate value. The cumulative effect is a more complex but opportunity-rich marketplace where differentiated clinical performance and integrated service models will define winners.

Assessment of 2025 tariff-driven supply chain responses and how manufacturers and providers adapted sourcing, inventory, and contracting to preserve clinical continuity

The introduction of tariffs and trade policy adjustments in 2025 introduced measurable pressures across medical device supply chains, with particular relevance to components and finished devices used in gastrointestinal bleeding management. Manufacturers that rely on cross-border sourcing of polymeric components, specialized adhesives, and high-precision electrical subsystems experienced increases in landed costs that prompted reassessments of geographic sourcing strategies and inventory practices. In response, several companies accelerated nearshoring initiatives and diversified supplier bases to protect continuity of supply and mitigate exposure to additional tariff actions.

Clinical providers encountered the downstream effects of these supply chain adjustments through tighter lead times and, in some cases, temporary product reallocations across facilities. Procurement teams intensified efforts to secure contract terms that included price protection clauses and prioritized suppliers with redundant manufacturing footprints. Regulatory compliance and quality management systems emerged as decisive differentiators, as buyers favored vendors with robust documentation and validated alternative sourcing approaches that minimize disruption risk.

While tariffs contributed to short-term cost pressures, the resultant strategic responses catalyzed enduring operational changes. Manufacturers made targeted capital investments to increase domestic manufacturing capacity and implemented design modifications to reduce reliance on tariff-impacted inputs. These measures, combined with more collaborative contracting and enhanced transparency across the supply chain, are contributing to a more resilient ecosystem even as policymakers continue to assess trade frameworks.

Comprehensive segmentation insights revealing how product types, technological approaches, clinical applications, end users, and indication subtypes determine adoption dynamics

A nuanced segmentation lens is essential to understand clinical adoption patterns and product development priorities across the gastrointestinal bleeding device space. Based on product type, endoscopic clips, hemostatic agents, injection therapies, and thermal devices each carry distinct clinical indications and operational profiles; hemostatic agents warrant closer attention because they span powder, sheets, and spray formats that offer varying deployment speed and surface conformity. Injection therapy comprises alcohol sclerosant, epinephrine, and polidocanol, with each agent selected based on lesion characteristics and operator preference, while thermal devices such as argon plasma coagulation, bipolar probes, and heater probes remain core tools for targeted coagulation.

From a technology standpoint, the market intersects endoscopic, radiologic, and surgical modalities. Endoscopic approaches are further differentiated into flexible and rigid endoscopy, reflecting procedural settings and access requirements; radiologic interventions include angiographic embolization and mesenteric stenting to manage bleeding inaccessible or refractory to endoscopy; surgical approaches continue to encompass laparoscopic and open surgery when definitive anatomic control is required. Application-based segmentation-encompassing angiodysplasia, Dieulafoy lesions, Mallory-Weiss tears, peptic ulcers, and variceal bleeding-illustrates how pathology-specific device choices and clinical pathways drive clinician preferences.

End-user segmentation includes ambulatory surgical centers, gastroenterology clinics, hospital inpatient services, and hospital outpatient departments, each with different throughput, capital intensity, and procurement cycles that influence purchasing decisions. Indication type divides the domain into lower and upper GI bleeding; lower GI further differentiates into colonic and rectal bleeding, while upper GI captures duodenal, esophageal, and gastric bleeding subtypes. Together, these overlapping segmentation dimensions reveal where innovation can yield differentiated clinical value, how reimbursement and setting-of-care considerations alter uptake, and where targeted clinical evidence will most effectively support adoption.

How regional payer structures, provider capabilities, and demographic trends shape differentiated demand patterns and technology adoption across global healthcare markets

Regional dynamics materially shape access models, reimbursement pathways, and technology adoption for gastrointestinal bleeding treatment devices across the world. In the Americas, integrated hospital systems and a highly consolidated supplier base create an environment where purchasing decisions weigh capital expenditures against procedural throughput and reimbursement incentives, and private payers frequently influence device selection and pricing negotiations. Continuous innovation cycles are supported by organized clinical networks and a relatively rapid path to adoption for minimally invasive technologies, provided they demonstrate clear clinical and economic benefits.

Across Europe, the Middle East & Africa, heterogeneous healthcare financing and regulatory frameworks lead to pronounced intra-regional variation. Countries with centralized health systems emphasize cost-effectiveness and standardized treatment pathways, which can slow adoption until robust comparative-effectiveness data are available, while emerging markets within the region may prioritize durable, lower-cost solutions that simplify logistics. In contrast, the Middle East exhibits pockets of rapid technology uptake driven by targeted healthcare investments and medical tourism initiatives.

Asia-Pacific presents a dual narrative: advanced markets pursue high-end endoscopic platforms and integrated imaging solutions, whereas other jurisdictions focus on expanding access to essential hemostatic devices through decentralized care models and cost-sensitive procurement. Across the region, demographic trends and rising prevalence of anticoagulant use are increasing clinical demand, prompting greater interest in scalable devices and training programs that enable wider adoption in both hospital and outpatient settings.

Competitive narratives emphasize integrated product portfolios, clinical evidence programs, and service models that accelerate adoption and strengthen long-term provider relationships

Competitive positioning among manufacturers is increasingly defined by integrated portfolios, evidence generation capabilities, and service-oriented business models. Leading device companies are investing in modular systems that pair hemostatic agents with dedicated delivery devices, as well as in training and support frameworks that mitigate learning-curve effects and accelerate hospital onboarding. Strategic partnerships between device innovators and clinical research networks are expanding real-world evidence generation, enabling clearer demonstration of procedural efficiency gains and clinical outcomes that resonate with both clinicians and payers.

Smaller, specialized firms are carving niches through material science advances and single-use disposables optimized for specific lesion types or access routes. These focused players often deploy agile commercialization approaches, leveraging targeted clinical publications and center-of-excellence relationships to build credibility. At the same time, larger manufacturers are pursuing horizontal consolidation and licensing agreements to acquire complementary technologies, create bundled offerings, and expand geographic reach, while emphasizing compliance, manufacturing scale, and post-market surveillance as competitive advantages.

Across the ecosystem, companies that align product development with clearly articulated clinical pathways and that support adoption through hands-on training, robust clinical data, and flexible commercial terms are better positioned to capture durable relationships with high-volume centers and integrated delivery networks.

Practical strategic actions for manufacturers and providers to convert clinical innovation into reliable adoption while strengthening supply chain and commercial resilience

Industry leaders should prioritize a set of actionable strategies that address clinical utility, operational resilience, and commercial differentiation. First, invest in clinical evidence generation that links device use to measurable outcomes such as reduced rebleeding rates, shorter procedure times, and lower overall episode-of-care costs; such data support payer discussions and strengthen hospital procurement cases. Second, design devices and accessory systems with supply chain redundancy in mind, reducing reliance on single-source components and enabling rapid substitution pathways in response to policy or logistical disruptions.

Third, develop comprehensive training and proctoring programs that shorten learning curves and embed product usage into standard clinical workflows, ensuring that value propositions translate into routine practice. Fourth, pursue flexible commercial models that include managed service agreements, volume-based pricing, and bundled procurement options tailored to ambulatory, inpatient, and outpatient settings. Fifth, accelerate digital enablement by integrating device telemetry, procedural documentation, and outcomes tracking to create compelling value narratives for providers and payers alike.

Taken together, these actions will help manufacturers and health systems convert clinical innovation into sustainable adoption while protecting margins and ensuring continuity of patient care in a dynamic policy and supply chain environment.

Robust multi-source approach combining clinician interviews, regulatory and technical documentation review, and real-world evidence synthesis to validate trends and insights

This research synthesizes peer-reviewed clinical literature, regulatory filings, product technical specifications, and interviews with procedural clinicians, hospital procurement leaders, and industry executives to assemble a multi-faceted view of the gastrointestinal bleeding device landscape. Primary qualitative insights were gathered through structured interviews with clinicians experienced in endoscopic, radiologic, and surgical management of bleeding, supplemented by anonymized discussions with supply chain and purchasing professionals to understand procurement constraints and contract preferences.

Secondary research included systematic review of clinical trial repositories, device registries, and regulatory documentation to map device indications, safety profiles, and labeling changes. Product literature and real-world evidence reports were analyzed to identify procedural workflows, device compatibility considerations, and training requirements. Cross-referencing of these inputs enabled triangulation of trends and validation of emergent themes. Wherever possible, methodological transparency was maintained by documenting interview protocols, inclusion criteria for literature sources, and the process used to reconcile conflicting evidence.

Limitations of the methodology are acknowledged: evolving device introductions and ongoing post-market studies can shift the evidence base, and access to proprietary hospital procurement data was constrained by confidentiality. To mitigate these limitations, the approach emphasized diversity of sources, iterative expert validation, and explicit notation of assumptions used during synthesis.

Synthesis of critical findings that link clinical innovation, supply chain resilience, and evidence-based adoption to long-term commercial and patient impact

In summary, the gastrointestinal bleeding treatment device sector is at the intersection of clinical necessity and technological opportunity. Advances in hemostatic agents, refined endoscopic accessories, and complementary radiologic options are expanding the therapeutic toolkit available to clinicians, while supply chain pressures and shifting payer expectations are reshaping how products are purchased and used. Strategic differentiation will increasingly depend on the ability to demonstrate clinical effectiveness within specific indication and care-setting contexts, to offer resilient supply and service models, and to provide scalable training that embeds new techniques into routine practice.

Stakeholders who align product development with validated clinical pathways and who invest in the generation of meaningful real-world outcomes will be best positioned to influence procurement decisions and achieve durable market presence. The convergence of digital enablement, targeted evidence generation, and adaptive commercial strategies creates a pathway for translating device innovation into consistent clinical benefit and commercial success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of AI-powered endoscopy platforms for real-time bleeding detection and management
  • 5.2. Development of novel hemostatic powders with targeted adhesion for upper gastrointestinal hemorrhage control
  • 5.3. Integration of telemedicine and remote monitoring solutions for post-endoscopic bleeding management in rural patients
  • 5.4. Emergence of biodegradable stent technologies for sustained esophageal variceal hemorrhage treatment
  • 5.5. Utilization of over-the-scope clips combined with injectable gels for refractory gastrointestinal bleeding cases
  • 5.6. Advancements in endoscopic suturing devices enabling precise defect closure in acute GI bleeding procedures
  • 5.7. Adoption of digital health platforms for real-time data analytics in gastrointestinal bleeding outcomes tracking

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastrointestinal Bleeding Treatment Devices Market, by Product Type

  • 8.1. Endoscopic Clips
  • 8.2. Hemostatic Agents
    • 8.2.1. Powder
    • 8.2.2. Sheets
    • 8.2.3. Spray
  • 8.3. Injection Therapy
    • 8.3.1. Alcohol Sclerosant
    • 8.3.2. Epinephrine
    • 8.3.3. Polidocanol
  • 8.4. Thermal Devices
    • 8.4.1. Argon Plasma Coagulation
    • 8.4.2. Bipolar Probes
    • 8.4.3. Heater Probes

9. Gastrointestinal Bleeding Treatment Devices Market, by Technology

  • 9.1. Endoscopic
    • 9.1.1. Flexible Endoscopy
    • 9.1.2. Rigid Endoscopy
  • 9.2. Radiologic
    • 9.2.1. Angiographic Embolization
    • 9.2.2. Mesenteric Stenting
  • 9.3. Surgical
    • 9.3.1. Laparoscopic Surgery
    • 9.3.2. Open Surgery

10. Gastrointestinal Bleeding Treatment Devices Market, by Application

  • 10.1. Angiodysplasia
  • 10.2. Dieulafoy Lesion
  • 10.3. Mallory-Weiss Tear
  • 10.4. Peptic Ulcer
  • 10.5. Variceal Bleeding

11. Gastrointestinal Bleeding Treatment Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Gastroenterology Clinics
  • 11.3. Hospitals Inpatient
  • 11.4. Hospitals Outpatient

12. Gastrointestinal Bleeding Treatment Devices Market, by Indication Type

  • 12.1. Lower GI
    • 12.1.1. Colonic Bleeding
    • 12.1.2. Rectal Bleeding
  • 12.2. Upper GI
    • 12.2.1. Duodenal Bleeding
    • 12.2.2. Esophageal Bleeding
    • 12.2.3. Gastric Bleeding

13. Gastrointestinal Bleeding Treatment Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Gastrointestinal Bleeding Treatment Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Gastrointestinal Bleeding Treatment Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Boston Scientific Corporation
    • 16.3.2. Medtronic plc
    • 16.3.3. Olympus Corporation
    • 16.3.4. FUJIFILM Holdings Corporation
    • 16.3.5. HOYA Corporation
    • 16.3.6. Cook Medical LLC
    • 16.3.7. Johnson & Johnson
    • 16.3.8. B. Braun Melsungen AG
    • 16.3.9. Teleflex Incorporated
    • 16.3.10. ConMed Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC CLIPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC CLIPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC CLIPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC CLIPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC CLIPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC CLIPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SHEETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SHEETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SHEETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SHEETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SHEETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SHEETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SPRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SPRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SPRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SPRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SPRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ALCOHOL SCLEROSANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ALCOHOL SCLEROSANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ALCOHOL SCLEROSANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ALCOHOL SCLEROSANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ALCOHOL SCLEROSANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ALCOHOL SCLEROSANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY EPINEPHRINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY EPINEPHRINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY EPINEPHRINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY EPINEPHRINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY EPINEPHRINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY EPINEPHRINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ARGON PLASMA COAGULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ARGON PLASMA COAGULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ARGON PLASMA COAGULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ARGON PLASMA COAGULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ARGON PLASMA COAGULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ARGON PLASMA COAGULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY BIPOLAR PROBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY BIPOLAR PROBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY BIPOLAR PROBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY BIPOLAR PROBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY BIPOLAR PROBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY BIPOLAR PROBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEATER PROBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEATER PROBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEATER PROBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEATER PROBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEATER PROBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEATER PROBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RIGID ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RIGID ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RIGID ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RIGID ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RIGID ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RIGID ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIOGRAPHIC EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIOGRAPHIC EMBOLIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIOGRAPHIC EMBOLIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIOGRAPHIC EMBOLIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIOGRAPHIC EMBOLIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIOGRAPHIC EMBOLIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MESENTERIC STENTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MESENTERIC STENTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MESENTERIC STENTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MESENTERIC STENTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MESENTERIC STENTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MESENTERIC STENTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIODYSPLASIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIODYSPLASIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIODYSPLASIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIODYSPLASIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIODYSPLASIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIODYSPLASIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DIEULAFOY LESION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DIEULAFOY LESION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DIEULAFOY LESION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DIEULAFOY LESION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DIEULAFOY LESION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DIEULAFOY LESION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MALLORY-WEISS TEAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MALLORY-WEISS TEAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MALLORY-WEISS TEAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MALLORY-WEISS TEAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MALLORY-WEISS TEAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MALLORY-WEISS TEAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PEPTIC ULCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PEPTIC ULCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PEPTIC ULCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PEPTIC ULCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PEPTIC ULCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PEPTIC ULCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY VARICEAL BLEEDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY VARICEAL BLEEDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY VARICEAL BLEEDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY VARICEAL BLEEDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY VARICEAL BLEEDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY VARICEAL BLEEDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTROENTEROLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTROENTEROLOGY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTROENTEROLOGY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTROENTEROLOGY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTROENTEROLOGY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTROENTEROLOGY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS INPATIENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS INPATIENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS INPATIENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS INPATIENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS INPATIENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS INPATIENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS OUTPATIENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS OUTPATIENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS OUTPATIENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS OUTPATIENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS OUTPATIENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COLONIC BLEEDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COLONIC BLEEDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COLONIC BLEEDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COLONIC BLEEDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COLONIC BLEEDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COLONIC BLEEDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RECTAL BLEEDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RECTAL BLEEDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RECTAL BLEEDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RECTAL BLEEDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RECTAL BLEEDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RECTAL BLEEDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DUODENAL BLEEDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DUODENAL BLEEDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DUODENAL BLEEDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DUODENAL BLEEDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DUODENAL BLEEDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DUODENAL BLEEDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ESOPHAGEAL BLEEDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ESOPHAGEAL BLEEDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ESOPHAGEAL BLEEDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ESOPHAGEAL BLEEDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ESOPHAGEAL BLEEDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ESOPHAGEAL BLEEDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTRIC BLEEDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTRIC BLEEDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTRIC BLEEDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTRIC BLEEDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTRIC BLEEDING, BY COUNTRY, 2018-2024